Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCarmell Therapeutics Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.14 | $20,519 | |||
| 08/14/2024 | Q2 2024 | -$0.16 | $12,320 | |||
| 03/29/2024 | Q1 2024 | -$0.21 | $0 | |||
| 12/30/2023 | Q4 2023 | $0.29 | $-3,728,816 | |||
| 09/29/2023 | Q3 2023 | -$0.62 | $3.73 M | |||
| 06/29/2023 | Q2 2023 | $0.02 | $0 | |||
| 03/29/2023 | Q1 2023 | $0.03 | $0 | |||
| 12/30/2022 | Q4 2022 | -$0.16 | $0 | |||
| 09/29/2022 | Q3 2022 | -$0.32 | $0 | |||
| 06/29/2022 | Q2 2022 | -$0.02 | $0 | |||
| 05/20/2022 | Q1 2022 | -$0.03 | $0 | |||
| 04/15/2022 | Q4 2021 | -$0.01 | $0 | |||
| 11/22/2021 | Q3 2021 | -$0.00 | $0 | |||
| 09/13/2021 | Q2 2021 | -$3,295.79 | $0 |
Carmell Therapeutics Corporation Earnings: FAQ's
When is Carmell Therapeutics Corporation's earnings date?
Carmell Therapeutics Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
How can I listen to Carmell Therapeutics Corporation's earnings conference
call?
The conference call for Carmell Therapeutics Corporation's latest earnings report can be listened to online.
How can I read Carmell Therapeutics Corporation's conference call transcript?
The conference call transcript for Carmell Therapeutics Corporation's latest earnings report can be read online.
How much profit does Carmell Therapeutics Corporation generate each year?
Carmell Therapeutics Corporation (:CTCX) has a recorded net income of $0. Carmell Therapeutics Corporation has generated $-1.46 earnings per share over the last four quarters.
What is Carmell Therapeutics Corporation's price-to-earnings ratio?
Carmell Therapeutics Corporation (:CTCX) has a price-to-earnings ratio of -2.07 and price/earnings-to-growth ratio is -0.03.